Placebo News and Research

RSS

D-cycloserine could help treat drug addiction

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory provide further evidence that a drug known as D-cycloserine could play a role in helping to extinguish the craving behaviors associated with drug addiction.

6 Nov 2007

Antibiotic that appears to control phobias may also be useful in treating addiction

6 Nov 2007

Bupropion plus counseling appears to help adolescents quit cigarette smoking in the short term

Almost one-fourth of U.S. high school students currently smoke cigarettes, according to background information in the article. Many teen smokers want to quit, but studies estimate that only about 4 percent of those who try are successful each year.

6 Nov 2007

Trial of the antidepressant fluoxetine for teens with depression and substance use disorders

The antidepressant fluoxetine combined with cognitive behavioral therapy appears as effective for treating depression among teens who also have substance use disorders as among those without substance abuse problems, according to a report in the November issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

6 Nov 2007

Vitamin A derivative associated with reduced growth in some lung cells

Treatment with a derivative of vitamin A called retinoic acid was associated with reduced lung cell growth in a group of former heavy smokers, according to a study published online October 30 in the Journal of the National Cancer Institute.

31 Oct 2007

Relief for seasonal allergic rhinitis sufferers

The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.

29 Oct 2007

Shire announces data from a 12-month study of Daytrana for ADHD

Shire plc has announced that data from a 12-month study of DAYTRANATM (methylphenidate transdermal system), the Attention Deficit Hyperactivity Disorder (ADHD) patch, demonstrated that DAYTRANA provided significant ADHD tolerability and symptom control improvement in children aged 6 to 12 years.

28 Oct 2007

Grape seed supplement studied for cardiovascular health benefits

Could some of the natural chemicals found in plants be powerful enough to improve cardiovascular health?

24 Oct 2007

Cannabis reduces pain only within a narrow dose range

Although smoking "moderate" doses of cannabis helps reduce pain in healthy research volunteers, pain is actually increased at high doses.

24 Oct 2007

Novel and inexpensive tool for identifying early signs of schizophrenia

A tendency to extract messages from meaningless noise could be an early sign of schizophrenia, according to a study by Yale School of Medicine researchers.

24 Oct 2007

Safety of nebulized Formoterol in COPD

Data from two Phase III clinical trials were presented today in Chicago at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians (ACCP), supporting the use of Perforomist (formoterol fumarate) Inhalation Solution as a safe and effective maintenance treatment for COPD patients.

24 Oct 2007

Low-dose aspirin for in vitro fertilisation

Although it is inexpensive, easy to obtain and poses little health risk, women undergoing in vitro fertilization (IVF) cannot rely upon aspirin to help them become pregnant, according to a systematic review of nine studies.

23 Oct 2007

One sniff may clear away that awful phobia!

Scientists from the University of New South Wales, Sydney, have found that a simple nasal spray may help people deal with irrational fears.

23 Oct 2007

Pine bark extract boosts nitric oxide production

A study to be published in the October edition of Hypertension Research reveals Pycnogenol, (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, helps individuals by enhancing healthy nitric oxide (NO) production which leads to an increase in blood flow and oxygen supply to muscles.

18 Oct 2007

Benefit of exenatide has not yet been proven

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly.

18 Oct 2007

Aspirin may really be a man's drug

First it was an apple, now it is an aspirin a day that may keep the doctor away.

18 Oct 2007

Prebiotics in infants for prevention of allergic disease and food hypersensitivity

Many parents add prebiotics and probiotics to children's food to help treat health problems, and according to two new reviews, the supplements might also help prevent eczema in babies at high risk.

17 Oct 2007

FDA approves raltegravir new HIV drug

The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

17 Oct 2007